Hainan Yue

Hainan Yue

Auto-generated profile, based on publicly available information

Hainan Yue

Department of Dermatology and Allergology University Graduate School of Medicine Tokyo Japan

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
RIRisa Ikutama
Risa Ikutama
GPGe Peng
Ge Peng
STSaya Tsukamoto
Saya Tsukamoto
YUYoshie Umehara
Yoshie Umehara
Juan Valentin Trujillo PaezJuan Valentin Trujillo Paez
Juan Valentin Trujillo Paez
François NiyonsabaFrançois Niyonsaba
François Niyonsaba

5 July 2019 in Allergy
Verified
Journal Article
Open access
PDF file
François NiyonsabaFrançois Niyonsaba
François Niyonsaba
PSPu Song
Pu Song
HYHainan Yue
Hainan Yue
NSNutda Sutthammikorn
Nutda Sutthammikorn
YUYoshie Umehara
Yoshie Umehara
HOHideoki Ogawa
Hideoki Ogawa
Click on the article title to read more.

28 January 2022 in Wound Repair and Regeneration
Verified
Journal Article
Open access
PDF file
HYHainan Yue
Hainan Yue
PSPu Song
Pu Song
NSNutda Sutthammikorn
Nutda Sutthammikorn
YUYoshie Umehara
Yoshie Umehara
Juan Valentin Trujillo PaezJuan Valentin Trujillo Paez
Juan Valentin Trujillo Paez
François NiyonsabaFrançois Niyonsaba
François Niyonsaba
Impaired keratinocyte functions are major factors that are responsible for delayed diabetic wound healing. In addition to its antimicrobial activity, the antimicrobial peptide derived from insulin-like growth factor-binding protein 5 (AMP-IBP5) activates mast cells and promotes keratinocyte and fibroblast proliferation and migration. However, its effects on diabetic wound healing remain unclear. Human keratinocytes were cultured in normal or high glucose milieus. The production of angiogenic growth factor and cell proliferation and migration were evaluated. Wounds in normal and streptozotocin-induced diabetic mice were monitored and histologically examined. We found that AMP-IBP5 rescued the high glucose-induced attenuation of proliferation and migration as well as the production of angiogenin and vascular endothelial growth factor in keratinocytes. AMP-IBP5-induced activity was mediated by the epidermal growth factor receptor, signal transducer and activator of transcription 1 and 3, and mitogen-activated protein kinase pathways, as indicated by the inhibitory effects of pathway-specific inhibitors. In vivo, AMP-IBP5 markedly accelerated wound healing, increased the expression of angiogenic factors and promoted vessel formation in both normal and diabetic mice. Overall, the finding that AMP-IBP5 accelerated diabetic wound healing by protecting against glucotoxicity and promoting angiogenesis suggests that AMP-IBP5 might be a potential therapeutic target for treating chronic diabetic wounds.